“We urge HHS, FDA, DHS, and CBP to delay any implementation of new procedures with respect to prescription medicines unless you can provide clear assurances that your agencies will not prevent genuine prescription medicines clearly intended for personal use and not appearing to present an unreasonable risk from entering the United States,” the members added.
Urge HHS, FDA, DHS, and CBP to delay new procedures for prescription-medicine mail shipments unless they can assure that genuine personal-use prescription medicines will not be prevented from entering the United States.
Occurrences
Evidence
No stored evidence yet.
Assessments
No assessments yet.